Literature DB >> 20233711

Direct and coordinate regulation of ATP-binding cassette transporter genes by Myc factors generates specific transcription signatures that significantly affect the chemoresistance phenotype of cancer cells.

Antonio Porro1, Michelle Haber, Daniel Diolaiti, Nunzio Iraci, Michelle Henderson, Samuele Gherardi, Emanuele Valli, Marcia A Munoz, Chengyuan Xue, Claudia Flemming, Manfred Schwab, Jason H Wong, Glenn M Marshall, Giuliano Della Valle, Murray D Norris, Giovanni Perini.   

Abstract

Increased expression of specific ATP-binding cassette (ABC) transporters is known to mediate the efflux of chemotherapeutic agents from cancer cells. Therefore, establishing how ABC transporter genes are controlled at their transcription level may help provide insight into the role of these multifaceted transporters in the malignant phenotype. We have investigated ABC transporter gene expression in a large neuroblastoma data set of 251 tumor samples. Clustering analysis demonstrated a strong association between differential ABC gene expression patterns in tumor samples and amplification of the MYCN oncogene, suggesting a correlation with MYCN function. Using expression profiling and chromatin immunoprecipitation studies, we show that MYCN oncoprotein coordinately regulates transcription of specific ABC transporter genes, by acting as either an activator or a repressor. Finally, we extend these notions to c-MYC showing that it can also regulate the same set of ABC transporter genes in other tumor cells through similar dynamics. Overall our findings provide insight into MYC-driven molecular mechanisms that contribute to coordinate transcriptional regulation of a large set of ABC transporter genes, thus affecting global drug efflux.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233711      PMCID: PMC2885232          DOI: 10.1074/jbc.M109.078584

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  48 in total

Review 1.  The human ATP-binding cassette (ABC) transporter superfamily.

Authors:  M Dean; A Rzhetsky; R Allikmets
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

Review 2.  Multidrug resistance in cancer: role of ATP-dependent transporters.

Authors:  Michael M Gottesman; Tito Fojo; Susan E Bates
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

3.  Germline mutations in the ribonuclease L gene in families showing linkage with HPC1.

Authors:  J Carpten; N Nupponen; S Isaacs; R Sood; C Robbins; J Xu; M Faruque; T Moses; C Ewing; E Gillanders; P Hu; P Bujnovszky; I Makalowska; A Baffoe-Bonnie; D Faith; J Smith; D Stephan; K Wiley; M Brownstein; D Gildea; B Kelly; R Jenkins; G Hostetter; M Matikainen; J Schleutker; K Klinger; T Connors; Y Xiang; Z Wang; A De Marzo; N Papadopoulos; O-P Kallioniemi; R Burk; D Meyers; H Grönberg; P Meltzer; R Silverman; J Bailey-Wilson; P Walsh; W Isaacs; J Trent
Journal:  Nat Genet       Date:  2002-01-22       Impact factor: 38.330

4.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.

Authors:  S Zhou; J D Schuetz; K D Bunting; A M Colapietro; J Sampath; J J Morris; I Lagutina; G C Grosveld; M Osawa; H Nakauchi; B P Sorrentino
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

Review 5.  Implications for RNase L in prostate cancer biology.

Authors:  Robert H Silverman
Journal:  Biochemistry       Date:  2003-02-25       Impact factor: 3.162

Review 6.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

Review 7.  Genetic parameters of neuroblastomas.

Authors:  Frank Westermann; Manfred Schwab
Journal:  Cancer Lett       Date:  2002-10-28       Impact factor: 8.679

8.  Mapping ATP-binding cassette transporter gene expression profiles in melanocytes and melanoma cells.

Authors:  Susanne Heimerl; Anja K Bosserhoff; Thomas Langmann; Josef Ecker; Gerd Schmitz
Journal:  Melanoma Res       Date:  2007-10       Impact factor: 3.599

9.  Identification of unknown target genes of human transcription factors using chromatin immunoprecipitation.

Authors:  Amy S Weinmann; Peggy J Farnham
Journal:  Methods       Date:  2002-01       Impact factor: 3.608

10.  Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.

Authors:  Siqin Wu; Cihan Cetinkaya; Maria J Munoz-Alonso; Natalie von der Lehr; Fuad Bahram; Vincent Beuger; Martin Eilers; Javier Leon; Lars-Gunnar Larsson
Journal:  Oncogene       Date:  2003-01-23       Impact factor: 9.867

View more
  37 in total

1.  Suppression of the ATP-binding cassette transporter ABCC4 impairs neuroblastoma tumour growth and sensitises to irinotecan in vivo.

Authors:  Jayne Murray; Emanuele Valli; Denise M T Yu; Alan M Truong; Andrew J Gifford; Georgina L Eden; Laura D Gamble; Kimberley M Hanssen; Claudia L Flemming; Alvin Tan; Amanda Tivnan; Sophie Allan; Federica Saletta; Leanna Cheung; Michelle Ruhle; John D Schuetz; Michelle J Henderson; Jennifer A Byrne; Murray D Norris; Michelle Haber; Jamie I Fletcher
Journal:  Eur J Cancer       Date:  2017-07-20       Impact factor: 9.162

2.  The RARS-MAD1L1 Fusion Gene Induces Cancer Stem Cell-like Properties and Therapeutic Resistance in Nasopharyngeal Carcinoma.

Authors:  Qian Zhong; Zhi-Hua Liu; Zhi-Rui Lin; Ze-Dong Hu; Li Yuan; Yan-Min Liu; Ai-Jun Zhou; Li-Hua Xu; Li-Juan Hu; Zi-Feng Wang; Xin-Yuan Guan; Jia-Jie Hao; Vivian W Y Lui; Ling Guo; Hai-Qiang Mai; Ming-Yuan Chen; Fei Han; Yun-Fei Xia; Jennifer R Grandis; Xing Zhang; Mu-Sheng Zeng
Journal:  Clin Cancer Res       Date:  2017-11-13       Impact factor: 12.531

3.  Curcumin sensitizes pancreatic cancer cells to gemcitabine by attenuating PRC2 subunit EZH2, and the lncRNA PVT1 expression.

Authors:  Kazuhiro Yoshida; Shusuke Toden; Preethi Ravindranathan; Haiyong Han; Ajay Goel
Journal:  Carcinogenesis       Date:  2017-10-01       Impact factor: 4.944

4.  ABCG2 Transporter Expression Impacts Group 3 Medulloblastoma Response to Chemotherapy.

Authors:  Marie Morfouace; Satish Cheepala; Sadhana Jackson; Yu Fukuda; Yogesh T Patel; Soghra Fatima; Daisuke Kawauchi; Anang A Shelat; Clinton F Stewart; Brian P Sorrentino; John D Schuetz; Martine F Roussel
Journal:  Cancer Res       Date:  2015-07-21       Impact factor: 12.701

5.  ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation.

Authors:  Guoliang Qing; Bo Li; Annette Vu; Nicolas Skuli; Zandra E Walton; Xueyuan Liu; Patrick A Mayes; David R Wise; Craig B Thompson; John M Maris; Michael D Hogarty; M Celeste Simon
Journal:  Cancer Cell       Date:  2012-11-13       Impact factor: 31.743

6.  miR-137 regulates the constitutive androstane receptor and modulates doxorubicin sensitivity in parental and doxorubicin-resistant neuroblastoma cells.

Authors:  A A Takwi; Y-M Wang; J Wu; M Michaelis; J Cinatl; T Chen
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

Review 7.  MYCN, neuroblastoma and focal adhesion kinase (FAK).

Authors:  Elizabeth A Beierle
Journal:  Front Biosci (Elite Ed)       Date:  2011-01-01

Review 8.  Pathologic effects of RNase-L dysregulation in immunity and proliferative control.

Authors:  Heather J Ezelle; Bret A Hassel
Journal:  Front Biosci (Schol Ed)       Date:  2012-01-01

9.  MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome.

Authors:  J Ryan; A Tivnan; J Fay; K Bryan; M Meehan; L Creevey; J Lynch; I M Bray; A O'Meara; L Tracey; A M Davidoff; R L Stallings
Journal:  Br J Cancer       Date:  2012-08-14       Impact factor: 7.640

10.  Inhibition of neuroblastoma tumor growth by targeted delivery of microRNA-34a using anti-disialoganglioside GD2 coated nanoparticles.

Authors:  Amanda Tivnan; Wayne Shannon Orr; Vladimir Gubala; Robert Nooney; David E Williams; Colette McDonagh; Suzanne Prenter; Harry Harvey; Raquel Domingo-Fernández; Isabella M Bray; Olga Piskareva; Catherine Y Ng; Holger N Lode; Andrew M Davidoff; Raymond L Stallings
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.